Search

everythinglearnresearchcommunity

for

Search:↓

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

A woman's liver problems improved after she stopped taking spironolactone.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

The document concludes that more research is needed to fully understand the causes of PCOS.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The document concludes that "Dictamnus" has a rich cultural history and potential as a herbal medicine, warranting more research into its effects and safety.

The Chinese version of the PCOS quality of life questionnaire is reliable and valid for Chinese-speaking women with PCOS.

Low-dose finasteride may cause fertility issues, but stopping it can improve sperm quality and lead to pregnancy.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Finasteride side effects in young men may be linked to specific gene variations.

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

Hair can be used to measure cancer-related chemicals noninvasively.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Young women with PCOS without additional risk factors may have normal heart function.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Nanoparticles show potential for controlled release of hair loss drugs, improving treatment effectiveness.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Dermoscopy effectively diagnoses and evaluates female hair loss treatment.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

No definitive link between finasteride and male breast cancer, but further research is needed.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Post-finasteride syndrome causes sexual, physical, and psychological symptoms, but more research is needed to understand its causes and connection to finasteride.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.